Pay in 4 interest-free payments of $7.14 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
You dont want to be losing so much weight so quickly
It is a triple agonist, meaning it activates GLP-1 (glucagon-like peptide-1), GIP (glucose- dependent insulinotropic polypeptide) and glucagon receptors making it one of the most comprehensive peptide candidates in obesity, insulin resistance and metabolic research
Research suggests it may support significant weight loss while also improving blood sugar control, insulin sensitivity, and other metabolic markers, which is why it is being closely watched as a potential dual-purpose therapy
Pack needles in your carry-on and bring your prescription label
By 12 weeks , average weight loss ranges from 35% of initial body weight, with this figure increasing to 1015% or more by 612 months in responders, particularly with higher-dose formulations like semaglutide 2.4 mg (Wegovy)
Compared to other weight loss approaches , tirzepatide demonstrates meaningful reductions in blood pressure, triglycerides, and inflammatory markers associated with cardiovascular risk
US$ 20.35
US$ 21.26
US$ 25.74
US$ 26.59
US$ 25.77
US$ 24.24
